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1. Introduction
  Leishmaniasis is an arthropod borne zoonotic disease 
transmitted through the bites of female sandflies. The old 
world leishmaniasis is caused principally by Leishmania 
donovani(L. donovani), Leishmania infantum (L. infantum), 
Leishmania tropica(L. tropica), Leishmania majoy (L. major) 
and Leishmania aethiopica(L. aethiopica )are transmitted 
by Phlebotomus species while parasites of the new world 
infections principally Leishmania peruriana (L. peruriana), 
Leishmania chagasi (L. chagasi), Leishmania mexicaca 
(L. mexicaca) complex and Leishmania braziliensis (L. 
braziliensis) complex are transmitted by sandflies of the 
genus Lutzomyia and Psychodopygus[1,2]. Leishmaniasis 
is broadly grouped into cutaneous, mucocutaneous and 
visceral types in line with the clinical manifestation of each 
infection. Cutaneous leishmaniasis is commonly caused by 
L. tropica, L. major, L. aethiopica, L. mexicana complex, L. 
braziliensis and L. peruviana while visceral leishmaniasis is 
caused by L. donovani, L. infantum which causes infantile 
visceral leishmaniasis and L. chagasi that causes the 
American type[3,4]. 
  There have been several reports of unusual clinical 
presentations of cutaneous leishmaniasis which often put 
to test both the clinical and laboratory competence of the 
management teams involved. Apart from presenting as 
pyrexia of unknown origin with attendant difficulties in 
diagnosis especially in climes where the disease is barely 
known, and also as tuberculous granulomatous skin lesions 
and non infectious sarcoid lesions, the disease may as well 
present with features mimicking malignant tumours[5-7]. In 
the present era of AIDS, leishmaniasis has also been found 
to be proportionately on the increase where the prevalence 
of AIDS is also high with more of its unusual clinical 
features expected[8-10].
  In view of the present global upsurge in the incidence of 
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cutaneous leishmaniasis with accompanying challenging 
clinical features, the disease could no doubt be classified 
as a re-emerging disease. This study was therefore set up to 
review the epidemiology, laboratory diagnosis and treatment 
of cutaneous leishmaniasis with in-depth discussion on 
unusual clinical presentations of the disease from available 
literatures on the disease in the tropical and sub-tropical 
parts of the world. This is to help raise the index of suspicion 
among clinicians who may be confronted with its myriad of 
complex clinical presentations[11-13].
  It is estimated that at least 14 million people globally 
are currently infected by Leishmania parasites in not 
less than 82 countries. The annual infection rate is put at 
2 million while at least 350 million (5.0%) of the world’s 
estimated 7 billion people are still at risk of acquiring 
leishmaniasis[14,15]. Also there are presently at least 1.5 
million new cases of cutaneous leishmaniasis alone each 
year. The disease is common in central Asia, Middle East, 
Indian sub-continent, Africa especially around Ethiopia, 
Eritrea and Somalia, Central America and western Peru[16-18].
  The classical clinical picture of cutaneous leishmaniasis 
is the formation of raised papules leading to formation 
of ulcers with clean cut margins and raised indurated 
edges called sores with accompanying varying degrees 
of immunosupression[19,20]. Post Kala-azar dermal 
leishmaniasis (PKDL) is caused by L. donovani ,  a 
causative agent of visceral leishmaniasis after about two 
years of treatment for the original disease. It presents as 
hypopigmented macules and indurations anywhere in the 
body especially the upper trunk[20-22].
  Laboratory diagnosis of cutaneous leishmaniasis is 
by detection of the amastigote forms of the parasites 
in macrophages from material obtained by puncture 
of indurated edge of the sore and stained by Wright or 
Giemsa stains. Promastigotes of the parasites may also be 
recovered from Novile Nicole Mc Neil (NNN), Hockmeyer’s 
or Schneider’s insect culture media inoculated with ulcer 
aspirates. The leishmanin skin test based on intradermal 
injection of leishmanin (killed promastigotes of L. tropica in 
0.5% phenol saline) is also sensitive and specific[24,25]. PKDL 
is diagnosed by microscopical examination of amastigote 
form of L. donovani by Leishman-stained smears of biopsy 
material from a nodular lesion[24-26]. Other diagnostic 
methods include: nested polymerase chain reaction (PCR), 
restriction fragment length polymorphism (RFLP) and other 
molecular methods, histology and cytology, chromatographic 
and immunohistochemical procedures[25,26].
  Leishmania parasites respond well to several antimicrobial 
agents, these include: pentavelent antimonials (sodium 
stibogluconate, megbumine antimoniate), aromatic 
derivatives (pentamidine), and other drugs such as 
monomycin, paromomycin, amonosidine, amphotericin B 
and allopurinol[26].
2. Clinical presentation of cutaneous leishmaniasis
  From 6 689 cases of cutaneous leishmaniasis in 778 
literature reviews studied, 76.80% (5 135) presented with 
classical cutaneous features of papules, nodules and ulcers 
while 23.20% (1 554) presented with unusual features.
  The less common modes of presentation of cutaneous 
leishmaniasis were as: pyrexia of unknown origin (PUO) 
5.19% (347), Non-specific cutaneous granulomatous 
dermatoses 1.17% (78), cutaneous myiasis 2.16% (145), 
mycetoma 0.90% (64) and lymphoproliferative malignancies 
0.99 (66) and post kala azar dermal leishmaniasis (PKDL) 
3.09% (207) (Table 1).  
  The most rare presentations of cutaneous leishmaniasis 
encountered were peritibial ulcerations, hard painful 
nipple in a male, swollen upper lip, dermatofibro sarcoma 
protuberans, sternal proliferative growth, turban tumour, post 
operative granuloma and cutaneous sterile pyogranuloma 
with asymmetrical alopecia 0.00% each (1-2) (Table 1).
  Other unusual presentations of cutaneous leishmaniasis 
were chalazion-like 0.14% (10), infected sebaceous cysts 
0.47% (32), syphilis 0.19% (13), yaws 0.13% (9), thrombotic 
ulcerations 0.40% (27), multiple myeloma 0.46% (31), 
sarcoidosis 0.67% (17), painless nasal solitary nodule 0.00% 
(2), tuberculous lymphadenopathy 0.25% (11), and unilateral 
erythema nodosum 0.28% (19) (Table 1).
3. Unusual clinical presentations of cutaneous 
leishmaniasis
  The most unusual clinical presentations of cutaneous 
leishmaniasis presently documented are: peritibial 
ulcerations, hard painful nipple in a male, swollen upper 
lip, dermatofibro sarcoma protuberans, sternal proliferative 
growth, turban tumour, post operative granuloma and 
cutaneous sterile pyogranuloma with asymmetrical 
alopecia 0.00% (<5) each. Similarly, chalazion-like 0.00%, 
infected sebaceous cysts 0.47%, syphilis 0.19%, yaws 
0.13%, thrombotic ulcerations 0.40%, multiple myeloma 
0.46%, sarcoidosis 0.67%, painless nasal solitary nodule 
0.00%, tuberculous lymphadenopathy 0.25% and unilateral 
erythema nodosum 0.28% were other rare clinical pictures 
of cutaneous leishmaniasis. This is in addition to the usual 
classical presentations of the disease which were found 
in 76.80% of cases as well as presentations as PKDL and 
as PUO. Fever, headache, weight loss, loss of appetite and 
varying haematological abnormalities were common features 
associated with various forms of presentation. 
  The association of symptoms such as fever, headache, 
weight loss and loss of appetite may delay or make 
diagnosis of the disease difficult especially in most tropical 
and subtropical regions of the world where several other 
infectious diseases such as malaria, typhoid, tuberculosis 
and human immunodeficiency virus (HIV) are still common 
and often present with similar symptoms as cutaneous 
leishmaniasis[27-29].  The disease may become more difficult 
in diagnosis in isolated imported cases occasioned by 
easy global integration and movement, and where index of 
suspicion may be extremely low among the local clinicians 
due to its absence in some communities[30-32]. Presentations 
in form of PUO and PKDL which were found to be common 
in India and Pakistan may even be more confusing where 
clinical history may not link with any immediate source 
of the infection hence making its early and immediate 
diagnosis difficult[32-34].
  Leishmaniasis has been found to create varying degrees 
of diagnostic dilemmas in different parts of the world: in 
Canada, leishmaniasis was found to present as cutaneous 
myiasis caused by Dermatobia hominis[34]; in Tunisia, 
erythema nodosum was the presenting feature[35]; while 
in Brazil, pyrexia of unknown origin (PUO) were found 
to be common presentations[36]. Also in USA, cutaneous 
leishmaniasis was found to present as sebaceous cysts 
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Table 1 
Clinical presentations of cutaneous leishmaniasis in 778 literature reviews on 6 689 cases [n(%)]. 
                            Clinical presentations Number
Usual presentations Papules, nodules, ulcers 5 135 (76.80)
Unusual presentations 
[1 554(23.20)]
Pyrexia of unknown origin    347 (5.19)
Post-Kala azar dermal leishmaniasis (PKDL)    207 (3.09)
Unilateral erythema nodosum mimicking allergic reactions      19 (0.28)
Non-specific cutaneous granulomatous dermatoses      78 (1.17)
Peritibial ulcerations        1 (0.01)
Mimicking tuberculous lymphadenopathy      17 (0.25)
Painless nasal solitary nodule        2 (0.01)
Asymetrical alopecia        2 (0.00)
Mimicking cutaneous diphtheria      67 (1.00)
Mimicking cutaneous tuberculosis      45 (0.67)
Mimicking tropical ulcers (buruli ulcer)      32 (0.47)
Non-specific pyodermas (caused by Staphylococcus aureus and 毬-haemolytic 
streptococci)
     54 (0.81)
Boggy superficial indurations      33 (0.49)
Sarcoidosis      45 (0.67)
Multiple myeloma      31 (0.46)
Gauchers disease      11 (0.16)
Lymphoproliferative malignancies( hodgkins and non-hodgkins lymphoma)      66 (0.99)
Perisinusoidal fibrosis + intrasinusoidal megakaryocytes+ kupffer cell hypertrophy      47 (0.70)
Chorioretinitis, uveitis      36 (0.54)
Central retinal vein thrombosis, flame shaped retinal haemorrhages      13 (0.19)
Papillitis, keratitis      41 (0.61)
Chalazion-like      10 (0.14)
Hard painful nipple in a male        1 (0.01)
Swollen upper lip        1 (0.01)
Thrombotic ulceration      27 (0.40)
Yaws        9 (0.13)
Syphilis      13 (0.19)
Dermatofibro sarcoma protuberans        1 (0.01)
Cutaneous + visceral leishmaniasis co-infection      29 (0.43)
Sternal proliferative growth      17 (0.25)
Hepatomegaly, splenomegaly, hepatosplenomegaly      83 (1.20)
Turban tumour        1 (0.01)
Cutaneous myiasis    145 (2.16)
Post-operative granuloma with no leishmania        1 (0.01)
Mycetoma      64 (0.90)
Infected sebaceous cyst      32 (0.47)
Cutaneous sterile pyogranuloma with asymmetrical alopecia        1 (0.01)
Leishmaniasis of the Lid (chalazion-like, ulcerous, phagedenic, cancer-like forms, 
Unilateral chronic granulomatous blepharitis)
     10 (0.14)
Non-specific dermal lesions      27 (0.40)
*Constitutional symptoms 
[4 176(60.04)]
Fever 2 291 (54.86)
Headache 1 558 (37.30)
Wasting 1 875 (44.89)
Weakness    993 (23.77)
Cachexia      77 (1.84)
Anorexia    685 (16.40)
Cough    131 (3.13)
*Laborataory findings  
[2 779(39.96)]
Anaemia 2 344 (84.34)
Pancytopaenia    433 (15.58)
Elevated plasma cell count    178 (6.41)
NB: Different features reported in same patient were grouped separately.
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caused by Staphylococcus aureus and Streptococcus 
pyogenes [37],  and as boggy induration mimicking 
malignancy[38]; while in the Netherlands, the disease was 
found to mimic buruli ulcers from immigrants[39]. The 
presentation of leishmaniasis as chalazion in Iran[40], 
mycetoma in India[41], and as a post-operative granuloma 
in Scotland[42] all constituted varying difficulties arriving at 
the exact diagnosis with delays in proper management of the 
patients.
  The main factors responsible for the delays or difficulties in 
arriving at the diagnosis of cutaneous leishmaniasis from the 
various studies were usually as a result of the presentations 
mimicking other diseases known for such presentations, 
and also the fact that, the amastigotes forms of the parasites 
were difficult to detect in several cases on microscopy[43-
45]. In other instances of diagnostic dilemma of cutaneous 
leishmaniasis, genetic methods such as PCR and RFLP still 
failed to establish diagnosis of cutaneous leishmaniasis 
until therapeutic trials were commenced which turned out 
to be the way forward[46,47]. The fact is that in classical cases 
of cutaneous leishmaniasis, parasites may be detected by 
microscopy or histology of biopsy specimens in less than 
70% of cases[48,49]. The finding of some of these cases in 
areas where leishmaniasis was rare or scarcely a public 
health issue further contributed to the difficulty in arriving 
at diagnosis[50-52].
  In view of the present global mass or individual movement 
of people and the increasing transmission of leishmaniasis, 
the disease is no doubt re-emerging with probably no 
territorial or geographical boundaries. Physicians practicing 
in regions where the disease is unknown or rare should 
consider it a possible encounter at any time in the course of 
their practice.
  Adequate facilities for laboratory diagnosis of leishmaniasis 
as well as that of other emerging diseases should be provided 
at clinics and hospitals especially in the developing world; 
these include histology/cytology, immunohistochemistry, 
polymerase chain reaction (PCR) and other genetic methods, 
culture and microscopy, so as to shorten the time and 
lighten the clinical and laboratory rigour towards arriving 
at definitive diagnosis. Regional governments should be 
sensitised towards influencing health policies so as to 
achieve these goals.
  In patients presenting with PUO where amastigotes prove 
difficult to detect with all available laboratory facilities, 
therapeutic trial should be considered a veritable treatment 
option. Physicians should always be aware and conscious of 
this fact. Physicians may need to look, and look again when 
carrying out physical examination of even very familiar 
cutaneous lesions and accommodate as many possibilities 
as possible especially in the present global changes in 
epidemiology of diseases.
  The authors wish to note that the data presented on 
cutaneous leishmaniasis in the present study is subject to 
certain variables and may not represent the most accurate 
up to date information on the disease. These include under-
diagnosis of the disease due to probably poor infrastructure 
from the developing world, under-reporting from health 
institutions due to varying degrees of competence in data 
management, unwillingness or inability to publish scientific 
findings, and also authors’ preference of specific data on 
the disease to present with greater clarity and accuracy in 
journal articles. These limitations are nevertheless well 
noted and should also be considered in the utilization of this 
piece of clinical information.
4. Conclusion
  The present study has shown that cutaneous leishmaniasis, 
in its myriad of unusual presentations are capable of 
confusing the most experienced physicians. Physicians 
therefore, while attending to patients with simple and often 
common cutaneous lesions should as well broaden their 
thoughts to accommodate possibly both immediate and 
remote possibilities such as cutaneous leishmaniasis so as 
to forestall probable ophthalmic, medical as well as surgical 
pitfalls.  
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